Simethicone by Innovida Pharmaeutique Corporation

Simethicone by

Drug Labeling and Warnings

Simethicone by is a Otc medication manufactured, distributed, or labeled by Innovida Pharmaeutique Corporation. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

SIMETHICONE- dimethicone tablet, chewable 
Innovida Pharmaeutique Corporation

----------

Active Ingredient (in each tablet)

Simethicone 125 mg

Purpose

Anti-gas

Uses

Relieves:

  • pressure 
  • bloating 
  • symptoms referred to as gas

Warnings

KEEP OUT OF REACH OF CHILDREN. In case of an overdose, get medical help or contact a Poison Control Center immediately

Directions

  • chew 1 to 2 tablets thoroughly as needed after meals and at bedtime
  • do not exceed 4 tablets in a 24 hour period except under the advice and supervision of a physician

Other Information

  • do not use if inner seal is broken
  • store at room temperature
  • avoid high humidity and excessive heat, above 40°C (104° F)

Inactive Ingredients

compressible sugar, dextrose, flavor, magnesium stearate, maltodextrin, microcrystalline cellulose, sorbitol.

Questions or Comments? 1-888-462-4166

Product label

image description

SIMETHICONE 
dimethicone tablet, chewable
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 71800-055
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DIMETHICONE (UNII: 92RU3N3Y1O) (DIMETHICONE - UNII:92RU3N3Y1O) DIMETHICONE125 mg
Inactive Ingredients
Ingredient NameStrength
SUGARCANE (UNII: 81H2R5AOH3)  
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
DEXTROSE, UNSPECIFIED FORM (UNII: IY9XDZ35W2)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
SORBITOL (UNII: 506T60A25R)  
Product Characteristics
ColorwhiteScoreno score
ShapeROUNDSize16mm
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 71800-055-0660 in 1 BOTTLE; Type 0: Not a Combination Product02/10/2025
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00202/10/202512/31/2025
Labeler - Innovida Pharmaeutique Corporation (080892908)

Revised: 12/2025
Document Id: 46e11d8b-7a1f-e5cb-e063-6394a90a35a2
Set id: 6638d4a9-605b-4409-ae4a-522b1da8aee6
Version: 2
Effective Time: 20251226